ATOS

Atossa Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Atossa Therapeutics Inc ATOS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.09 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.09
more quote information »

Recent News

Date Time Source Heading
6/02/202216:05GLOBEAtossa Therapeutics Appoints Biotech Industry Communications..
5/18/202209:30GLOBEAtossa Therapeutics to Present at the H.C. Wainwright Global..
5/16/202218:24EDGARStatement of Changes in Beneficial Ownership (4)
5/16/202209:03EDGARCurrent Report Filing (8-k)
5/09/202216:10EDGARQuarterly Report (10-q)
5/09/202216:05GLOBEAtossa Therapeutics Announces First Quarter 2022 Financial..
5/09/202216:02EDGARCurrent Report Filing (8-k)
4/27/202209:30GLOBEAtossa Therapeutics to Present at the Q2 Investor Summit..
4/20/202209:30GLOBEAtossa Therapeutics Announces Completion of Part B of..
4/11/202216:06EDGARProxy Statement (definitive) (def 14a)
4/01/202216:02EDGARProxy Statement - Notice of Shareholders Meeting..
3/23/202209:30GLOBEAtossa Therapeutics to Present at the Maxim Group 2022..
3/09/202208:31SEEKSTLA, SI and HTOO among pre market gainers
3/08/202209:40SEEKAtossa Therapeutics issued patent covering breast cancer..
3/08/202209:15GLOBEAtossa Therapeutics Announces Issuance of Key U.S. Patent..
2/28/202217:39EDGARStatement of Changes in Beneficial Ownership (4)
2/28/202217:39EDGARStatement of Changes in Beneficial Ownership (4)
2/28/202216:58SEEKAtossa Therapeutics GAAP EPS of -$0.18
2/28/202216:41EDGARAnnual Report (10-k)
2/28/202216:15GLOBEAtossa Therapeutics Announces Year-End 2021 Financial..
2/14/202215:17EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202216:16EDGARStatement of Ownership (sc 13g)
1/27/202209:30GLOBEAtossa Therapeutics President and CEO Dr. Steven C. Quay..
1/18/202209:30GLOBEAtossa Therapeutics Announces Advancement to Part B..
12/22/202109:30GLOBEAtossa Therapeutics Begins Enrollment of Phase 2 Clinical..
12/16/202109:00PRNUSPhysician-Scientist Steven Quay Calls for International..
12/06/202109:15GLOBEAtossa Therapeutics Completes Pre-IND Meeting with U.S. Food..
11/24/202109:30GLOBERegistration Is Now Open For The Tribe Public Webinar Event..
11/15/202109:33SEEKAtossa Therapeutics EPS beats by $0.02
11/15/202109:31EDGARQuarterly Report (10-q)
11/15/202109:30GLOBEAtossa Therapeutics Announces Third Quarter 2021 Financial..
11/15/202109:26EDGARCurrent Report Filing (8-k)
10/21/202109:30GLOBEAtossa Therapeutics CEO Dr. Steven Quay Emphasizes..
10/06/202116:41EDGARCurrent Report Filing (8-k)
9/30/202109:30GLOBEAtossa Therapeutics Begins Enrollment in Clinical Study of..
9/10/202113:48TRMN3 Reasons to Love Atossa Therapeutics Stock
9/08/202107:31EDGARCurrent Report Filing (8-k)
9/07/202117:20GLOBEAtossa Therapeutics Adjourns Special Stockholder Meeting to..
9/02/202109:30GLOBEAtossa Therapeutics Receives Approval from the Swedish..
8/17/202113:08TRMNAtossa: Strong Balance Sheet Will Support the Pipeline’s..
8/13/202109:31EDGARCurrent Report Filing (8-k)
8/13/202109:30GLOBEAtossa Therapeutics Announces Second Quarter 2021 Financial..
8/09/202116:02EDGARProxy Statement (definitive) (def 14a)
8/05/202109:30GLOBEAtossa Therapeutics to Present at the BTIG Virtual..
7/31/202116:40SEEKFlora Growth leads weekly healthcare gainers;..
7/30/202111:00SEEKERYTECH Pharma, Allied Healthcare Products leads healthcare..
7/30/202109:51SEEKAtossa loses a tenth after convening a special meeting for..
7/29/202116:03EDGARProxy Statement - Notice of Shareholders Meeting..
7/26/202109:00PRNUSPhysician-Scientist Steven Quay: Forensic examination of..
7/16/202112:10SEEKAtossa in selloff for second straight session after sharp..
Your Recent History
NASDAQ
ATOS
Atossa The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220701 07:20:09